Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000914121-04-001865
Filing Date
2004-09-09
Accepted
2004-09-09 17:22:32
Documents
9
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT im090804-10k.txt 10-K 278105
2 BOND FINANCING AGREEMENT im090804-ex10_22.txt EX-10.22 275131
3 SUBSIDIARIES OF THE COMPANY im090804-ex21_1.txt EX-21.1 509
4 CONSENT OF ERNST & YOUNG LLP im090804-ex23_1.txt EX-23.1 694
5 CONSENT OF KPMG LLP im090804-ex23_2.txt EX-23.2 816
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER im090804-ex31_1.txt EX-31.1 3139
7 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER im090804-ex31_2.txt EX-31.2 3169
8 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER im090804-ex32_1.txt EX-32.1 1343
9 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER im090804-ex32_2.txt EX-32.2 1363
  Complete submission text file 0000914121-04-001865.txt   566917
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12104 | Film No.: 041023675
SIC: 2835 In Vitro & In Vivo Diagnostic Substances